Dezerv

Fund Overview

Fund Size

Fund Size

₹62 Cr

Expense Ratio

Expense Ratio

1.21%

ISIN

ISIN

INF397L01LK4

Minimum SIP

Minimum SIP

₹500

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

28 Feb 2019

About this fund

LIC MF Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by LIC Mutual Fund. This fund has been in existence for 5 years, 1 months and 26 days, having been launched on 28-Feb-19.
As of 22-Apr-24, it has a Net Asset Value (NAV) of ₹25.66, Assets Under Management (AUM) of 61.69 Crores, and an expense ratio of 1.21%.
  • LIC MF Healthcare Fund Direct Growth has given a CAGR return of 20.10% since inception.
  • The fund's asset allocation comprises around 94.98% in equities, 0.00% in debts, and 5.02% in cash & cash equivalents.
  • You can start investing in LIC MF Healthcare Fund Direct Growth with a SIP of ₹500 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+46.49%

+46.92%(Cat. Avg.)

3 Years

+12.14%

+14.70%(Cat. Avg.)

5 Years

+20.48%

+22.04%(Cat. Avg.)

Since Inception

+20.10%

--%(Cat. Avg.)

Portfolio Summaryas of 31st March 2024

Equity58.59 Cr94.98%
Others3.1 Cr5.02%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity9.18 Cr14.88%
Zydus Lifesciences LtdEquity4.6 Cr7.46%
J.B. Chemicals & Pharmaceuticals LtdEquity3.87 Cr6.27%
Piramal Pharma LtdEquity3.57 Cr5.78%
Cipla LtdEquity3.53 Cr5.71%
Torrent Pharmaceuticals LtdEquity3.23 Cr5.23%
Apollo Hospitals Enterprise LtdEquity3.18 Cr5.15%
Dr Reddy's Laboratories LtdEquity3.14 Cr5.10%
TrepsCash - Repurchase Agreement3.02 Cr4.90%
Divi's Laboratories LtdEquity2.86 Cr4.64%
Abbott India LtdEquity2.78 Cr4.51%
Ipca Laboratories LtdEquity2.65 Cr4.30%
Alkem Laboratories LtdEquity2.39 Cr3.87%
Global Health LtdEquity2.38 Cr3.86%
Metropolis Healthcare LtdEquity2.36 Cr3.83%
Syngene International LtdEquity2.23 Cr3.61%
Artemis Medicare Services Ltd Ordinary SharesEquity2.08 Cr3.37%
Mankind Pharma LtdEquity1.99 Cr3.23%
Glenmark Pharmaceuticals LtdEquity1.36 Cr2.20%
Laurus Labs LtdEquity1.22 Cr1.98%
Net Receivables / (Payables)Cash0.08 Cr0.12%

Allocation By Market Cap (Equity)

Large Cap Stocks

43.94%

Mid Cap Stocks

25.73%

Small Cap Stocks

25.31%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare58.59 Cr94.98%

Risk & Performance Ratios

Standard Deviation

This fund

15.08%

Cat. avg.

15.23%

Lower the better

Sharpe Ratio

This fund

0.65

Cat. avg.

0.85

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.50

Higher the better

Fund Managers

Karan Doshi

Karan Doshi

Since July 2023

Additional Scheme Detailsas of 31st March 2024

ISININF397L01LK4Expense Ratio1.21%Exit Load1.00%Fund Size₹62 CrAge28 Feb 2019Lumpsum Minimum₹5,000Fund StatusOpen Ended Investment CompanyBenchmarkS&P BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹12.94 Cr52.9%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹699.55 Cr55.6%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹699.55 Cr53.4%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹39.74 Cr49.8%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹160.39 Cr48.0%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹160.39 Cr45.0%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2235.15 Cr48.8%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2235.15 Cr46.6%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹643.07 Cr49.4%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.53 Cr48.6%

About the AMC

LIC Mutual Fund

LIC Mutual Fund

Total AUM

₹1,109 Cr

Address

4th Floor, Industrial Assurance Building, Mumbai, 400 020

Other Funds by LIC Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
LIC MF Gold ETF FOF Direct Growth

High Risk

0.3%1.0%₹48.87 Cr22.3%
LIC MF Equity Savings Fund Direct Growth

Moderately High risk

1.0%1.0%₹14.64 Cr17.9%
LIC MF Nifty Next 50 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹73.87 Cr63.1%
LIC MF Focused 30 Equity Direct Growth

Very High Risk

1.6%1.0%₹130.45 Cr26.0%
LIC MF Long Term Value Fund Direct Growth

Very High Risk

1.6%1.0%₹106.92 Cr37.6%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹61.69 Cr46.5%
LIC MF Small Cap Fund Direct Growth

Very High Risk

1.5%1.0%₹208.67 Cr47.8%
LIC MF Midcap Fund Direct Growth

Very High Risk

1.6%1.0%₹242.21 Cr50.2%
LIC MF Dividend Yield Fund Direct Growth

Very High Risk

1.4%1.0%₹129.23 Cr53.3%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of LIC MF Healthcare Fund Direct Growth, as of 22-Apr-2024, is ₹25.66.
The fund has generated 46.49% over the last 1 year and 12.14% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 94.98% in equities, 0.00% in bonds, and 5.02% in cash and cash equivalents.
The fund managers responsible for LIC MF Healthcare Fund Direct Growth are:-
  1. Karan Doshi